ATXS ASTRIA THERAPEUTICS INC

Ownership history in BAILARD, INC.  ·  2 quarters on record

This page tracks every 13F SEC filing in which BAILARD, INC. reported a position in ASTRIA THERAPEUTICS INC (ATXS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 26,500 0% 0.00% $193K $7.28
2025 Q2 INITIATED 26,500 0.00% $142K $5.36
% of Fund (quarterly)    ATXS price (monthly, adj. close)
← Back to BAILARD, INC. Holdings